GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹111 Cr | ₹108 Cr | ₹125 Cr | ₹159 Cr | ₹179 Cr |
What is the latest Total Non-Current Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹111 Cr |
Mar2024 | ₹108 Cr |
Mar2023 | ₹125 Cr |
Mar2022 | ₹159 Cr |
Mar2021 | ₹179 Cr |
How is Total Non-Current Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹111 Cr | 2.80 | |
Mar2024 | ₹108 Cr | -14.10 | |
Mar2023 | ₹125 Cr | -21.01 | |
Mar2022 | ₹159 Cr | -11.16 | |
Mar2021 | ₹179 Cr | - |
Compare Total Non-Current Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹54,206.3 Cr | -3% | -5% | 24.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹414,533.0 Cr | 3.6% | 2.5% | 6.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,215.0 Cr | -2.9% | 1.5% | 48.1% | Stock Analytics | |
CIPLA | ₹120,428.0 Cr | -0.1% | -2.4% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹116,410.0 Cr | 2.5% | 4.9% | 15.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,253.0 Cr | -0.7% | -6.4% | -5.2% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | -3% |
-5% |
24.5% |
SENSEX | -1.4% |
1.8% |
3.3% |
You may also like the below Video Courses